Health ❯ Healthcare ❯ Regulatory Affairs

European Medicines Agency

Drug Approval Process Marketing Authorization Drug Safety Drug Regulation Committee for Medicinal Products for Human Use Drug Reviews CHMP Review Process Orphan Medicinal Products CHMP Opinion Approval Process CHMP Opinions Drug Approval Conditional Marketing Authorization Prac Recommendations EU-M4all Programme

11 ARTICLES

3mo ago

Wegovy Pill Arrives in UK Private Market as Clinicians Flag Dosing and Safety Risks

Private pharmacies are already dispensing the daily oral semaglutide tablet, which changes access patterns, raises monitoring needs, increases counterfeit risk.

4 ARTICLES

5mo ago

EU Panel Recommends Braftovi Plus Cetuximab and FOLFOX for First‑Line BRAF‑Mutant Colorectal Cancer

4 ARTICLES

5mo ago

CHMP Backs Expanded EU Use of Mounjaro for Diabetes in Patients 10+ and Adult Weight Management

3 ARTICLES

last yr.

EMA Panel Recommends Rejecting Rezurock for Chronic Graft-Versus-Host Disease in EU

9 ARTICLES

last yr.

GLP-1 Agonists Tied to Higher Risk of Macular Degeneration and Rare Optic Neuropathy

European Medicines Agency

Wegovy Pill Arrives in UK Private Market as Clinicians Flag Dosing and Safety Risks

EU Panel Recommends Braftovi Plus Cetuximab and FOLFOX for First‑Line BRAF‑Mutant Colorectal Cancer

EMA Recommends Jascayd for Two Progressive Lung Fibrosis Conditions

EMA Backs Single-Dose Acoziborole for Gambiense Sleeping Sickness Outside EU

EMA Panel Backs Higher 7.2 mg Wegovy Dose for Obesity

CHMP Backs Expanded EU Use of Mounjaro for Diabetes in Patients 10+ and Adult Weight Management

EMA Panel Recommends Rejecting Rezurock for Chronic Graft-Versus-Host Disease in EU

GLP-1 Agonists Tied to Higher Risk of Macular Degeneration and Rare Optic Neuropathy